Alexion Pharmaceuticals: Nice Earnings, Too Expensive?
October 23, 2014 at 15:08 PM EDT
On a day when biotech stocks like Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN) and Celgene (CELG) are flying, few are flying higher than Alexion Pharmaceuticals (ALXN). Alexion has gained 7.1% after the biotech company reported a profit of $127 a share, topping analyst forecasts for $1.15. Alexion also raised its full-year guidance to between $5.15 and $5.20 [...]